For decades , therapists have struggled to find viable therapies for treatment-resistant mood disorders. Now suggests copyright therapy, administered typically intravenously , may offer a significant opportunity for patients who haven't benefited from standard therapies. While largely considered an experimental intervention, initial research are sh